Physical Education
elahe malekyian fini; Mahbubeh Motefakker; , Sajad Ahmadizad; morteza salimian; fatemeh mokhtari Andani
Volume 30, Issue 2 , July and August 2023, , Pages 284-300
Abstract
Introduction: Diabetes is one of the most important health problems in the world. The aim of this study was to evaluate the response of a session of resistance exercise with blood flow restriction (REBFR) to hemodynamic and hematological changes in type 2 diabetic patients.Materials and Methods: Fifteen ...
Read More
Introduction: Diabetes is one of the most important health problems in the world. The aim of this study was to evaluate the response of a session of resistance exercise with blood flow restriction (REBFR) to hemodynamic and hematological changes in type 2 diabetic patients.Materials and Methods: Fifteen patients with type 2 diabetes performed knee flexion and extension of the resistance exercise with and without BFR in two sessions with intensity of 20% and 80% 1RM, respectively. Hemodynamic and hematological changes were measured at before, immediately and 30 minutes after exercise. Repeated analysis of variance was used to evaluate the effect of the intervention on quantitative factors.Results: The mean values of systolic and diastolic blood pressure and heart rate values in both training sessions were not significantly different (P <0.05). The results showed that there was no significant difference between WBC, RBC, HCT, Hb, MCH, MCHC, MCV and PV indices between resistance exercise sessions with and without BFR (P <0.05). According to the findings, the amount of RBC and Hb increased significantly immediately after REBFR (P <0.05), which returned to resting levels after 30 minutes of recovery.Conclusion: Low-intensity REBFR due to no significant change in hemodynamic, hematological and platelet parameters can be an effective and low-cost mechanism in preventing cardiovascular disease in patients with type 2 diabetes and as a Non-pharmacological treatment system and alternative to high-intensity resistance exercise to prevent muscle atrophy, especially in clinical populations, especially diabetics.